• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多相改良生酮饮食改变肠道微生物群来促进肥胖个体减肥。

Weight Loss Promotion in Individuals with Obesity through Gut Microbiota Alterations with a Multiphase Modified Ketogenic Diet.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.

出版信息

Nutrients. 2023 Sep 27;15(19):4163. doi: 10.3390/nu15194163.

DOI:10.3390/nu15194163
PMID:37836447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10574165/
Abstract

The occurrence of obesity and related metabolic disorders is rising, necessitating effective long-term weight management strategies. With growing interest in the potential role of gut microbes due to their association with responses to different weight loss diets, understanding the mechanisms underlying the interactions between diet, gut microbiota, and weight loss remains a challenge. This study aimed to investigate the potential impact of a multiphase dietary protocol, incorporating an improved ketogenic diet (MDP-i-KD), on weight loss and the gut microbiota. Using metagenomic sequencing, we comprehensively analyzed the taxonomic and functional composition of the gut microbiota in 13 participants before and after a 12-week MDP-i-KD intervention. The results revealed a significant reduction in BMI (9.2% weight loss) among obese participants following the MDP-i-KD intervention. Machine learning analysis identified seven key microbial species highly correlated with MDP-i-KD, with exhibiting the highest response. Additionally, the co-occurrence network of the gut microbiota in post-weight-loss participants demonstrated a healthier state. Notably, metabolic pathways related to nucleotide biosynthesis, aromatic amino acid synthesis, and starch degradation were enriched in pre-intervention participants and positively correlated with BMI. Furthermore, species associated with obesity, such as and , played pivotal roles in regulating these metabolic activities. In conclusion, the MDP-i-KD intervention may assist in weight management by modulating the composition and metabolic functions of the gut microbiota. , and could be key targets for gut microbiota-based obesity interventions.

摘要

肥胖症和相关代谢紊乱的发生率不断上升,因此需要有效的长期体重管理策略。由于肠道微生物与不同减肥饮食的反应有关,它们的潜在作用引起了越来越多的关注,因此了解饮食、肠道微生物群和减肥之间相互作用的机制仍然是一个挑战。本研究旨在探讨多相饮食方案(MDP-i-KD)对减肥和肠道微生物群的潜在影响。使用宏基因组测序,我们全面分析了 13 名参与者在 12 周 MDP-i-KD 干预前后肠道微生物群的分类和功能组成。结果表明,MDP-i-KD 干预后肥胖参与者的 BMI 显著降低(体重减轻 9.2%)。机器学习分析确定了与 MDP-i-KD 高度相关的 7 种关键微生物物种,其中 表现出最高的反应。此外,减肥后参与者的肠道微生物群共现网络显示出更健康的状态。值得注意的是,与核苷酸生物合成、芳香族氨基酸合成和淀粉降解相关的代谢途径在干预前参与者中富集,并与 BMI 呈正相关。此外,与肥胖相关的物种,如 和 ,在调节这些代谢活动中发挥着关键作用。总之,MDP-i-KD 干预可能通过调节肠道微生物群的组成和代谢功能来帮助进行体重管理。 、 和 可能是基于肠道微生物群的肥胖干预的关键靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/23f7af3d6988/nutrients-15-04163-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/235f8b13f3b0/nutrients-15-04163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/69f2e4736b43/nutrients-15-04163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/3c4ce68b7a4c/nutrients-15-04163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/4ab23d2d37ca/nutrients-15-04163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/203453810cf8/nutrients-15-04163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/28d50ff56a87/nutrients-15-04163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/23f7af3d6988/nutrients-15-04163-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/235f8b13f3b0/nutrients-15-04163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/69f2e4736b43/nutrients-15-04163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/3c4ce68b7a4c/nutrients-15-04163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/4ab23d2d37ca/nutrients-15-04163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/203453810cf8/nutrients-15-04163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/28d50ff56a87/nutrients-15-04163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a3f/10574165/23f7af3d6988/nutrients-15-04163-g007.jpg

相似文献

1
Weight Loss Promotion in Individuals with Obesity through Gut Microbiota Alterations with a Multiphase Modified Ketogenic Diet.通过多相改良生酮饮食改变肠道微生物群来促进肥胖个体减肥。
Nutrients. 2023 Sep 27;15(19):4163. doi: 10.3390/nu15194163.
2
A multiphase dietetic protocol incorporating an improved ketogenic diet enhances weight loss and alters the gut microbiome of obese people.一种包含改良生酮饮食的多相饮食方案可增强肥胖人群的减重效果并改变其肠道微生物组。
Int J Food Sci Nutr. 2022 Mar;73(2):238-250. doi: 10.1080/09637486.2021.1960957. Epub 2021 Aug 6.
3
Modulating the Human Gut Microbiota through Hypocaloric Balanced Diets: An Effective Approach for Managing Obesity.通过低热量均衡饮食调节人体肠道微生物群:管理肥胖的有效方法。
Nutrients. 2023 Jul 11;15(14):3101. doi: 10.3390/nu15143101.
4
Long-term dietary intervention reveals resilience of the gut microbiota despite changes in diet and weight.长期饮食干预可使肠道微生物组保持稳定,尽管饮食和体重发生了变化。
Am J Clin Nutr. 2020 Jun 1;111(6):1127-1136. doi: 10.1093/ajcn/nqaa046.
5
The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition.极低热量、极低热量生酮饮食和极低碳水化合物饮食对肠道微生物组成的潜在作用。
Front Endocrinol (Lausanne). 2021 May 14;12:662591. doi: 10.3389/fendo.2021.662591. eCollection 2021.
6
The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications.生酮饮食对肠道微生物群的影响:潜在的益处、风险和适应证。
Nutrients. 2023 Aug 22;15(17):3680. doi: 10.3390/nu15173680.
7
The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.极低卡路里生酮饮食对肥胖人群肠道微生物组成的影响。
Nutrients. 2023 Jun 13;15(12):2728. doi: 10.3390/nu15122728.
8
Gut Microbiota Serves a Predictable Outcome of Short-Term Low-Carbohydrate Diet (LCD) Intervention for Patients with Obesity.肠道微生物群可预测肥胖患者短期低碳水化合物饮食 (LCD) 干预的结果。
Microbiol Spectr. 2021 Oct 31;9(2):e0022321. doi: 10.1128/Spectrum.00223-21. Epub 2021 Sep 15.
9
Normal diet ameliorates obesity more safely and effectively than ketogenic diet does in high-fat diet-induced obesity mouse based on gut microbiota and lipid metabolism.正常饮食比生酮饮食更能安全有效地改善肥胖,这是基于高脂肪饮食诱导肥胖小鼠的肠道微生物群和脂质代谢得出的结果。
Int J Food Sci Nutr. 2023 Sep;74(5):589-605. doi: 10.1080/09637486.2023.2235899. Epub 2023 Jul 20.
10
Intermittent fasting, calorie restriction, and a ketogenic diet improve mitochondrial function by reducing lipopolysaccharide signaling in monocytes during obesity: A randomized clinical trial.间歇性禁食、热量限制和生酮饮食通过减少肥胖期间单核细胞中的脂多糖信号来改善线粒体功能:一项随机临床试验。
Clin Nutr. 2024 Aug;43(8):1914-1928. doi: 10.1016/j.clnu.2024.06.036. Epub 2024 Jul 5.

引用本文的文献

1
Elevated mevalonolactone from Ruminococcus torques contributes to metabolically unhealthy obesity development.来自扭链瘤胃球菌的甲羟戊酸内酯升高会导致代谢不健康的肥胖症发展。
J Biol Chem. 2025 Jun;301(6):110281. doi: 10.1016/j.jbc.2025.110281. Epub 2025 May 22.
2
Advancing Obesity Management: the Very Low-Energy Ketogenic therapy (VLEKT) as an Evolution of the "Traditional" Ketogenic Diet.推进肥胖管理:极低能量生酮疗法(VLEKT)作为“传统”生酮饮食的演变
Curr Obes Rep. 2025 Apr 3;14(1):30. doi: 10.1007/s13679-025-00622-2.
3
The microbiome's influence on obesity: mechanisms and therapeutic potential.

本文引用的文献

1
The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA .肠道微生物群通过长非编码 RNA 重新编程肠道脂质代谢。
Science. 2023 Aug 25;381(6660):851-857. doi: 10.1126/science.ade0522. Epub 2023 Aug 24.
2
Sex Difference in the Associations among Obesity-Related Indices with Hyperuricemia in a Large Taiwanese Population Study.在一项大型台湾人群研究中,肥胖相关指标与高尿酸血症之间的关联存在性别差异。
Nutrients. 2023 Aug 1;15(15):3419. doi: 10.3390/nu15153419.
3
Associations of non-traditional cardiovascular risk factors and body mass index with metabolic syndrome in the Chinese elderly population.
微生物群对肥胖的影响:机制与治疗潜力。
Sci China Life Sci. 2025 Mar;68(3):657-672. doi: 10.1007/s11427-024-2759-3. Epub 2024 Nov 28.
4
The Ambiguous Correlation of with Obesity: A Systematic Review.[具体事物]与肥胖的模糊关联:一项系统综述。 (原文中“with Obesity”前缺少具体事物,所以翻译时用[具体事物]代替)
Microorganisms. 2024 Aug 26;12(9):1768. doi: 10.3390/microorganisms12091768.
5
Diet and the Gut Microbiome as Determinants Modulating Metabolic Outcomes in Young Obese Adults.饮食与肠道微生物群作为调节年轻肥胖成年人代谢结果的决定因素
Biomedicines. 2024 Jul 18;12(7):1601. doi: 10.3390/biomedicines12071601.
6
Nutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial.营养保健品通过重塑微生物群来改善细胞因子和生活质量从而提高健康水平:巴西的一项双盲随机试验。
Sci Rep. 2024 May 15;14(1):11127. doi: 10.1038/s41598-024-61909-3.
中国老年人群中,非传统心血管危险因素及体重指数与代谢综合征的相关性。
Diabetol Metab Syndr. 2023 Jun 16;15(1):129. doi: 10.1186/s13098-023-01047-4.
4
Association between serum uric acid and measures of adiposity in Chinese adults: a cross-sectional study.血清尿酸与中国成年人肥胖指标的关系:一项横断面研究。
BMJ Open. 2023 May 24;13(5):e072317. doi: 10.1136/bmjopen-2023-072317.
5
Roles of the gut microbiome in weight management.肠道微生物组在体重管理中的作用。
Nat Rev Microbiol. 2023 Aug;21(8):535-550. doi: 10.1038/s41579-023-00888-0. Epub 2023 May 3.
6
Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment.肠道微生物群对植物雌激素的功能生物转化及其对癌症治疗的影响。
J Nutr Biochem. 2023 Aug;118:109368. doi: 10.1016/j.jnutbio.2023.109368. Epub 2023 Apr 25.
7
Intermittent fasting modulates the intestinal microbiota and improves obesity and host energy metabolism.间歇性禁食调节肠道微生物群,改善肥胖和宿主能量代谢。
NPJ Biofilms Microbiomes. 2023 Apr 7;9(1):19. doi: 10.1038/s41522-023-00386-4.
8
Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.生酮饮食和低脂饮食对阿尔茨海默病高危成年人的代谢组、微生物组和食物组的影响。
Alzheimers Dement. 2023 Nov;19(11):4805-4816. doi: 10.1002/alz.13007. Epub 2023 Apr 5.
9
Contemporary medical, device, and surgical therapies for obesity in adults.成人肥胖的当代医学、器械及手术治疗方法。
Lancet. 2023 Apr 1;401(10382):1116-1130. doi: 10.1016/S0140-6736(22)02403-5. Epub 2023 Feb 9.
10
Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation.整合血清蛋白质组学和粪便宏蛋白质组学以分析超重/肥胖对炎症性肠病的影响:一项初步调查。
Clin Proteomics. 2023 Feb 9;20(1):6. doi: 10.1186/s12014-023-09396-y.